Nitorum Capital L.P. Cuts Stock Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

Nitorum Capital L.P. trimmed its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 7.6% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 200,045 shares of the medical instruments supplier's stock after selling 16,408 shares during the period. ICU Medical accounts for 3.6% of Nitorum Capital L.P.'s portfolio, making the stock its 12th largest holding. Nitorum Capital L.P. owned approximately 0.82% of ICU Medical worth $31,041,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of ICUI. Harvest Fund Management Co. Ltd bought a new position in ICU Medical during the fourth quarter valued at $33,000. Murphy & Mullick Capital Management Corp bought a new position in ICU Medical during the fourth quarter valued at $52,000. Venturi Wealth Management LLC lifted its position in ICU Medical by 64.0% during the fourth quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock valued at $82,000 after purchasing an additional 206 shares during the last quarter. Russell Investments Group Ltd. lifted its position in ICU Medical by 88.8% during the fourth quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock valued at $99,000 after purchasing an additional 300 shares during the last quarter. Finally, Sterling Capital Management LLC lifted its holdings in shares of ICU Medical by 813.5% in the 4th quarter. Sterling Capital Management LLC now owns 676 shares of the medical instruments supplier's stock worth $105,000 after acquiring an additional 602 shares during the last quarter. 96.10% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ICUI has been the subject of several analyst reports. Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a report on Tuesday, April 8th. Raymond James set a $97.00 target price on shares of ICU Medical in a report on Wednesday, March 12th. StockNews.com lowered shares of ICU Medical from a "buy" rating to a "hold" rating in a report on Thursday. Finally, KeyCorp lowered their target price on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a report on Monday, April 21st. Two research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $162.67.

ICU Medical Trading Up 0.2 %

ICUI traded up $0.24 on Monday, reaching $135.90. 297,693 shares of the company traded hands, compared to its average volume of 274,101. ICU Medical, Inc. has a one year low of $95.44 and a one year high of $196.26. The firm has a fifty day simple moving average of $143.25 and a two-hundred day simple moving average of $157.64. The company has a market cap of $3.34 billion, a P/E ratio of -29.74 and a beta of 0.86. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.